News Archive

Currently, lung cancer screening exams are recommended for high-risk adults. These patients have at
least a 20 pack year cigarette smoking history. A pack year is calculated by the number of packs a person
smokes per day multiplied by the number of years that person has smoked.

Sora Ely, MD, has joined the George Washington (GW) University Cancer Center and the GW Medical Faculty Associates as a Thoracic Surgeon.

Now that the leaves are changing color and the sun is tucking in behind the horizon earlier each evening,
viruses and colds are making their seasonal rounds. It’s a tough season for everyone, but it’s especially
problematic for cancer patients whose immune systems are already…

For many, it’s a season of joy. But for those dealing with a cancer diagnosis, whether it’s for the first time or an ongoing issue, the festive season may not be at the top of their lists.
What are the best ways patients and caregivers can cope with the dual stresses of the holidays and…

Jennifer Vaz, MD, joined the George Washington University (GW) Cancer
Center and the GW Medical Faculty Associates as a Gynecological Oncologist.

Fayez Estephan, MD, joined the George Washington (GW) University Cancer Center
and GW School of Medical and Health Sciences (SMHS) as Assistant Professor of Medicine in the Division
of Hematology and Oncology

Lekhaj Daggubati, MD, MS has joined the George Washington (GW) University Cancer Center and The GW Medical Faculty Associates as Director of Surgical Neuro-Oncology.

The GW Cancer Center is pleased to announce the appointment of Pavani Chalasani, MD, MPH, to serve as the new director of the Division of Hematology and Medical Oncology at the GW Medical Faculty Associates.

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the selection of Hematology and Oncology Fellows, Walaa Aldhahri, MBBS, and Zoë McKinnell, MD, as the 2023 Albert L. Tucker and Elizabeth T. Tucker Postdoctoral Fellowship awardees.

A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.